Cerity Partners’s Cantel Medical Corporation CMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-201,031
Closed -$15.9M 762
2020
Q4
$15.9M Hold
201,031
0.51% 41
2020
Q3
$8.83M Hold
201,031
0.36% 58
2020
Q2
$8.89M Sell
201,031
-150
-0.1% -$5.6K 0.49% 40
2020
Q1
$7.22M Buy
201,181
+150
+0.1% +$8.53K 0.45% 44
2019
Q4
$14.3M Buy
201,031
+49,050
+32% +$3.56M 0.73% 25
2019
Q3
$11.4M Hold
151,981
0.67% 31
2019
Q2
$12.3M Sell
151,981
-342
-0.2% -$24K 0.77% 26
2019
Q1
$10.2M Buy
152,323
+133,194
+696% +$10.1M 0.69% 28
2018
Q4
$1.42M Sell
19,129
-45
-0.2% -$3.71K 0.1% 187
2018
Q3
$1.76M Buy
19,174
+17
+0.1% +$1.62K 0.12% 180
2018
Q2
$1.88M Sell
19,157
-42
-0.2% -$4.7K 0.14% 162
2018
Q1
$2.14M Sell
19,199
-133,215
-87% -$14.9M 0.16% 146
2017
Q4
$15.7M Hold
152,414
1.05% 16
2017
Q3
$14.4M Buy
152,414
+149,308
+4,807% +$11.8M 1.02% 16
2017
Q2
$252K Sell
3,106
-148,875
-98% -$11.2M 0.02% 309
2017
Q1
$12.2M Buy
+151,981
New +$12.1M 1.02% 14

Other funds holding CMD

Cerity Partners's CMD Position: Q1 2021 in Review

Cerity Partners sold out of Cantel Medical Corporation (CMD) in Q1 2021, closing a stake of 201,031 shares — an estimated $15.9M sold.

Cerity Partners first reported a position in CMD in Q1 2017 and held it in 16 quarters. The position peaked at $15.9M in Q4 2020. 234 funds tracked by Wall St. Rank hold CMD as of Q1 2021.

  • Cerity Partners reported no remaining Cantel Medical Corporation position as of Q1 2021 after selling out during the quarter.
  • Cerity Partners sold 201,031 Cantel Medical Corporation shares in Q1 2021, an estimated $15.9M.
  • Cerity Partners first reported a position in Cantel Medical Corporation in Q1 2017 and held it in 16 quarters.
  • Cerity Partners's Cantel Medical Corporation position peaked at $15.9M in Q4 2020.
  • 234 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q1 2021.

Based on Cerity Partners's 13F filing for Q1 2021, filed 12 May 2021.